miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axisChaojie Liang(Central South University), Jixiang Wu(Capital Medical University)OncotargetNovember 18, 201710.18632/oncotarget.22504Cited by 25SaveCiteExport RISWatch citationsRelated PapersShort-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial|Surgical Endoscopy|2018|100<p>The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis</p>|OncoTargets and Therapy|2019|13